Negotiations on possible exceptions to copyright for specific actors such as libraries, archives, universities and research institutions at the World Intellectual Property Organization have been stalling for years.
As the pharmaceutical industry continues to shift toward biologic-based drugs, including monoclonal antibodies, protecting the underlying technology has been and continues to be a priority for companies.
This week on Capitol Hill is another light one in terms of hearings focusing on topics related to technology and innovation.
By Kevin E. Noonan -- Last week, the Supreme Court denied certiorari to Regeneron Pharmaceuticals in its appeal of the Federal Circuit's decision in Regeneron Pharmaceuticals v.
McDonnell Boehnen Hulbert & Berghoff LLP and Patent Docs will be hosting a CLE program on Biopharma Patent Law from 9:30 am to 1:00 pm on October 24, 2018 at the Boston Marriott Cambridge in Cambridge, MA.
October 9, 2018 - "Avoiding and Utilizing Prosecution History Traps: Litigation, Prosecution, and Due Diligence" (Intellectual Property Owners Association) - 2:00 to 3:00 pm (ET) October 9, 2018 - "Leveraging a Harmonized Patent Classification Sys
The Federal Circuit recently issued a ruling reversing the district court’s denial of Apple Inc.’s (“Apple”) motion for judgment as a matter of law (“JMOL”) after finding no reasonable juror could have found infringement based on the evidence pres
The trade dispute between the US and China started with a US accusation of intellectual property theft on the part of China. Is China really “stealing” intellectual property? I’m not so sure.
Trademarks protect distinctive marks, such as brand names, logos, and designs. This protection allows a trademark holder to exclude others from using the mark without permission of the owner.
More than three years after naming and shaming Ericsson's privateering deal with Optis Wireless (among a long list of similar partnerships), I became aware of t